Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Prevention of Hyperbilirubinemia in Rh Hemolytic Disease of Newborns
NCT00288600Phase 4Completed
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Oct 2006
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in hemolytic disease of the fetus and newborn (HDFN), sponsored by Fundação Oswaldo Cruz. Started Oct 2006; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
hemolytic disease of the fetus and newborn (HDFN)
Beyond the preview
Go deeper on NCT00288600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288600.